Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
-
$775 Million Settlement – Washington Public Power Supply System Securities Litigation
In re Washington Public Power Supply System Securities Litigation, MDL 551 (D. Ariz.)In this massive securities fraud litigation, Milberg served as Co-Lead Counsel for a class that obtained, after several months of trial, settlements totaling $775 million, the largest securities fraud settlement at that time. -
$400+ Million Settlement – Chantix (Varenicline) Products Liability Litigation
In re Chantix (Varenicline) Products Liability Litigation, MDL 2092 (U.S. District Court for the Northern District of Alabama, Southern Division)Milberg attorneys served as Co-Lead Counsel in the Chantix Coordination in New York State Court and court-appointed member of the Plaintiffs Steering Committee in the MDL in Alabama. -
$178.6 Million Settlement – AK Steel ERISA Class Action
Merkner et al. v. AK Steel Corp., No. 09-423 (S.D. Ohio)Milberg attorneys were part of a team that won a $178.6 million class action settlement for a class of retired workers of the AK Steel Butler Works Plant. Retirees claimed that AK Steel negotiated to reduce their medical benefits without their consent, in violation of the Employee Retirement Income Security Act (ERISA). -
$90 Million Settlement – Royal Dutch/Shell Transport ERISA Litigation
In re Royal Dutch/Shell Transport ERISA Litigation, No. 04-1398 (D.N.J.)An ERISA breach of fiduciary duty class action against the Royal Dutch/Shell Oil Group of Companies on behalf of certain of the companies’ U.S. employee investment plan participants. The $90 million settlement included important provisions regarding the monitoring and training of individuals appointed to be ERISA fiduciaries. -
$2.4 Billion Settlement – ACTOS Antitrust Litigation
In re Actos End Payor Antitrust Litigation, Case No. 1:13-cv-09244 (U.S. District Court for the Southern District of New York)Milberg attorneys played a significant role in this litigation, including appointment to the MDL Discovery Committee, which accused Takeda Pharmaceuticals of failing to warn patients of the risks of bladder cancer, heart failure and other side effects associated with the Type 2 diabetes drug. In 2015, roughly 9,000 claims were settled for $2.4 billion and significant injunctive relief.